Comparison of Different Dynamic Contrast Enhanced-Magnetic Resonance Imaging Descriptors and Clinical Findings Among Breast Cancer Subtypes Determined Based on Molecular Assessment

被引:2
作者
Dogan, Serap [1 ]
Ozmen, Soner [2 ]
Oz, Bahadir [3 ]
Imamoglu, Hakan [1 ]
Kahriman, Guven [1 ]
Zararsiz, Gokmen [4 ]
Ozturk, Mustafa [1 ]
机构
[1] Erciyes Univ, Dept Radiol, Med Fac, TR-38090 Kayseri, Turkey
[2] Gumushane State Hosp, Dept Radiol, Gumushane, Turkey
[3] Erciyes Univ, Dept Gen Surg, Med Fac, Kayseri, Turkey
[4] Erciyes Univ, Dept Biostat, Med Fac, Kayseri, Turkey
关键词
Breast Cancer; Dynamic-Contrast Enhanced Breast MRI; Molecular Subtypes; FEATURES; CLASSIFICATION; TUMORS; MRI; RECURRENCE; PROGNOSIS; PATTERNS; RECEPTOR; THERAPY;
D O I
10.5812/iranjradiol.64889
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Breast cancer is a heterogeneous disease with different molecular and histologic subtypes, clinical behaviors and prognosis. The same stage of disease and similar histopathological characteristics may show different treatment responses. Identification of breast cancer subtypes has become important for planning the targeted therapy and personalized management of patients. Objectives: To compare the clinicopathologic findings, dynamic contrast enhanced-magnetic resonance imaging (DCE-MRI) characteristics and associated MRI findings among breast cancer molecular subtypes. Patients and Methods: 267 pathologically proven invasive breast cancers in 263 patients were included. Clinicopathological findings, DCE-MRI findings and associated MRI findings were retrospectively evaluated and compared among breast cancer subtypes. Results: Invasive ductal carcinoma was the most common histological tumor type (87.6%). There were 222 (83.1%) masses and 45 (16.9%) non-mass enhancements. The molecular subtypes were luminal A in 174 (65.1%), luminal B in 45 (16.9%), human epidermal growth factor receptor 2 (HER2) positive in 24 (9%) and triple negative (TN) in 24 (9%) of the lesions. Spiculated mass margin was significantly associated with luminal A breast cancer (45.2%) and irregular shape was significantly more common in luminal A (86.3%) and luminal B lesions (95.1%) (P < 0.001). Larger mass size (P= 0.027), non-mass enhancement (P= 0.005), perilesional+ prepectoral edema and skin + perilesional+ prepectoral edema were significantly associated with HER2 positive breast cancer (P= 0.001). Higher histological grade, oval mass shape, circumscribed mass margin, intratumoral high/very high signal intensity on T2 weighted image (T2WI) were significantly associated with TN breast cancer (P < 0.001). Conclusion: Histological grade, size and morphological features of masses on DCE-MRI, intratumoral signal intensity on T2WI and edema pattern would be helpful to distinguish breast cancer subtypes.
引用
收藏
页数:11
相关论文
共 24 条
[1]   Correlation between MR imaging - prognosis factors and molecular classification of breast cancers [J].
Alili, C. ;
Pages, E. ;
Doyon, F. Curros ;
Perrochia, H. ;
Millet, I. ;
Taourel, P. .
DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2014, 95 (02) :235-242
[2]  
[Anonymous], 2013, BREAST IM REP DAT SY
[3]   Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation [J].
Boudin, Laurys ;
Chabannon, Christian ;
Sfumato, Patrick ;
Sabatier, Renaud ;
Bertucci, Francois ;
Tarpin, Carole ;
Provansal, Magali ;
Houvenaegel, Gilles ;
Lambaudie, Eric ;
Tallet, Agnes ;
Resbeut, Michel ;
Charafe-Jauffret, Emmanuelle ;
Calmels, Boris ;
Lemarie, Claude ;
Boher, Jean-Marie ;
Extra, Jean-Marc ;
Viens, Patrice ;
Goncalves, Anthony .
EUROPEAN JOURNAL OF CANCER, 2016, 57 :118-126
[4]   The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes [J].
Carey, Lisa A. ;
Dees, E. Claire ;
Sawyer, Lynda ;
Gatti, Lisa ;
Moore, Dominic T. ;
Collichio, Frances ;
Ollila, David W. ;
Sartor, Carolyn I. ;
Graham, Mark L. ;
Perou, Charles M. .
CLINICAL CANCER RESEARCH, 2007, 13 (08) :2329-2334
[5]   Magnetic Resonance Imaging Features in Triple-Negative Breast Cancer: Comparison With Luminal and HER2-Overexpressing Tumors [J].
Costantini, Melania ;
Belli, Paolo ;
Distefano, Daniela ;
Bufi, Enida ;
Di Matteo, Marialuisa ;
Rinaldi, Pierluigi ;
Giuliani, Michela ;
Petrone, Gianluigi ;
Magno, Stefano ;
Bonomo, Lorenzo .
CLINICAL BREAST CANCER, 2012, 12 (05) :331-339
[6]   Triple-negative breast cancer: Clinical features and patterns of recurrence [J].
Dent, Rebecca ;
Trudeau, Maureen ;
Pritchard, Kathleen I. ;
Hanna, Wedad M. ;
Kahn, Harriet K. ;
Sawka, Carol A. ;
Lickley, Lavina A. ;
Rawlinson, Ellen ;
Sun, Ping ;
Narod, Steven A. .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4429-4434
[7]   Multimodality Imaging of Triple Receptor-Negative Tumors With Mammography, Ultrasound, and MRI [J].
Dogan, Basak E. ;
Gonzalez-Angulo, Ana Maria ;
Gilcrease, Michael ;
Dryden, Mark J. ;
Yang, Wei Tse .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (04) :1160-1166
[8]  
Edge SB, 2009, AJCC CANC STAGING MA, P347
[9]   Can Breast Cancer Molecular Subtype Help to Select Patients for Preoperative MR Imaging? [J].
Grimm, Lars J. ;
Johnson, Karen S. ;
Marcom, P. Kelly ;
Baker, Jay A. ;
Soo, Mary S. .
RADIOLOGY, 2015, 274 (02) :352-358
[10]   Breast Cancer Molecular Subtype as a Predictor of the Utility of Preoperative MRI [J].
Ha, Richard ;
Jin, Brian ;
Mango, Victoria ;
Friedlander, Lauren ;
Miloshev, Vesco ;
Malak, Sharp ;
Wynn, Ralph .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 204 (06) :1354-1360